Conduct Phase III CT: Akum Pharmaceutical Receives Information on Antidiabetic FDC from CDSCO Panel.

Published Date: 11 Dec 2023

New Delhi: Under the Central Drug Standard Control, the Subject Expert Committee (SEC) has rejected the proposal for a waiver of clinical trial requirements.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot